 OncoCytes pipeline of genomics-based cancer treatments bode well for its growth in the coming decade and OCX stock is already up 90 year-to-date. The post Best Stocks for 2021: OCX Got Off to a Fast Start But the Best Is Yet to Come appeared first on InvestorPlace. 